| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |